Affordable in-house antiretroviral drug resistance assay with good performance in non-subtype B HIV-1
- 14 November 2009
- journal article
- research article
- Published by Elsevier BV in Journal of Virological Methods
- Vol. 163 (2), 505-508
- https://doi.org/10.1016/j.jviromet.2009.11.011
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Varied Patterns of HIV-1 Drug Resistance on Failing First-Line Antiretroviral Therapy in South AfricaJAIDS Journal of Acquired Immune Deficiency Syndromes, 2010
- Antiretroviral Drug Resistance Testing in Adult HIV‐1 Infection: 2008 Recommendations of an International AIDS Society–USA PanelClinical Infectious Diseases, 2008
- Prevalence of HIV‐1 Drug Resistance after Failure of a First Highly Active Antiretroviral Therapy Regimen in KwaZulu Natal, South AfricaClinical Infectious Diseases, 2008
- Update of the drug resistance mutations in HIV-1: Spring 2008.2008
- The requirement for surveillance of HIV drug resistance within antiretroviral rollout in the developing worldCurrent Opinion in Infectious Diseases, 2006
- Performance of the Celera Diagnostics ViroSeq HIV-1 Genotyping System for Sequence-Based Analysis of Diverse Human Immunodeficiency Virus Type 1 StrainsJournal of Clinical Microbiology, 2004
- Performance Characteristics of the TRUGENEHIV-1Genotyping Kit and the Opengene DNA Sequencing SystemJournal of Clinical Microbiology, 2003
- Immunopathogenic Mechanisms of HIV InfectionAnnals of Internal Medicine, 1996